文献速递皮肤肿瘤

黑色素瘤Mohs显微描记手术:前瞻性多中心研究

Mohs micrographic surgery for melanoma: A prospective multicenter study.
PubMed 文献 · J Am Acad Dermatol · 2019-05-28

本研究在美国3家学术机构和8家私人诊所前瞻性纳入562例黑色素瘤,评估冷冻切片Mohs显微描记手术(MMS)联合黑色素瘤抗原 recognized by T cells 1(MART-1)免疫组化的应用。躯干/四肢原发黑色素瘤10mm切缘、头颈黑色素瘤12mm切缘可使97%肿瘤达到组织学阴性切缘;每例肿瘤平均费用1328.46美元。

要点

  • MMS联合MART-1免疫组化可安全实现组织保留与当日重建。
  • 未行全面切缘评估时,躯干/四肢切缘至少10mm、头颈至少12mm。
  • 每例肿瘤平均治疗费用为1328.46美元。

核心结论

  • MMS联合MART-1免疫组化可安全实现组织保留、当日重建并获得组织学阴性切缘。
  • 未采用全面切缘评估时,躯干/四肢原发黑色素瘤初始切缘至少10mm、头颈至少12mm,可达97%组织学阴性切缘。

研究设计与样本

  • 前瞻性、多中心、队列研究,纳入562例接受MMS联合MART-1免疫组化治疗的黑色素瘤。
  • 研究场所为美国3家学术机构和8家私人诊所。

主要发现

  • 躯干和四肢原发黑色素瘤(非浸润性和浸润性)在10mm切缘下97%达到组织学阴性切缘。
  • 头颈部黑色素瘤需12mm切缘才能使97%肿瘤达到组织学阴性切缘。
  • 每例接受治疗的肿瘤总体平均费用为1328.46美元。

关键数值与推荐

  • 躯干/四肢原发黑色素瘤:10mm切缘,97%组织学阴性。
  • 头颈部黑色素瘤:12mm切缘,97%组织学阴性。
  • 每例肿瘤总体平均费用:1328.46美元。

临床怎么用

  • 对黑色素瘤采用MMS联合MART-1免疫组化可在单日内完成组织学验证的肿瘤清除与重建。
  • 若因条件限制无法行100%切缘组织学评估,可按部位选择至少10mm(躯干/四肢)或12mm(头颈)的初始手术切缘。

局限性

  • 研究为非随机、非对照研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Single-institution studies show that frozen section Mohs micrographic surgery (MMS) is an effective treatment modality for cutaneous melanoma, but no multi-institutional studies have been published. OBJECTIVE: To characterize the use of MMS in the treatment of melanoma at 3 academic and 8 private practices throughout the United States, to recommend excision margins when 100% histologic margin evaluation is not used, and to compare actual costs of tumor removal with MMS vs standard surgical excision. METHODS: Prospective, multicenter, cohort study of 562 melanomas treated with MMS with melanoma antigen recognized by T cells 1 immunostaining. RESULTS: Primary trunk and extremity melanomas (noninvasive and invasive melanoma) achieved histologically negative margins in 97% of tumors with 10-mm margins, whereas 12-mm margins were necessary to achieve histologically negative margins in 97% of head and neck melanomas. Overall average cost per tumor treated was $1328.46. LIMITATIONS: Nonrandomized and noncontrolled study. CONCLUSIONS: MMS with melanoma antigen recognized by T cells 1 immunostaining safely provides tissue conservation and same-day reconstruction of histologically verified tumor-free margins in a convenient, single-day procedure. When comprehensive margin evaluation is not used, initial surgical margins of at least 10 mm for primary trunk/extremity and 12 mm for head/neck melanomas should be used to achieve histologically negative margins 97% of the time.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Ellison PM, Zitelli JA, Brodland DG, et al. Mohs micrographic surgery for melanoma: A prospective multicenter study. J Am Acad Dermatol. 2019. PMID: 31150700. doi:10.1016/j.jaad.2019.05.057

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。